Literature DB >> 22051601

Personalized cell transfer immunotherapy for B-cell malignancies and solid cancers.

Steven A Rosenberg1, James N Kochenderfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22051601      PMCID： PMC3222537          DOI： 10.1038/mt.2011.223

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  42 in total

1.  Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.

Authors:  Cor H J Lamers; Stefan Sleijfer; Arnold G Vulto; Wim H J Kruit; Mike Kliffen; Reno Debets; Jan W Gratama; Gerrit Stoter; Egbert Oosterwijk
Journal:  J Clin Oncol       Date:  2006-05-01       Impact factor: 44.544

Review 2.  Adoptive immunotherapy for cancer: building on success.

Authors:  Luca Gattinoni; Daniel J Powell; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

3.  Transduction of an IL-2 gene into human melanoma-reactive lymphocytes results in their continued growth in the absence of exogenous IL-2 and maintenance of specific antitumor activity.

Authors:  K Liu; S A Rosenberg
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 4.  Cancer/testis antigens, gametogenesis and cancer.

Authors:  Andrew J G Simpson; Otavia L Caballero; Achim Jungbluth; Yao-Tseng Chen; Lloyd J Old
Journal:  Nat Rev Cancer       Date:  2005-08       Impact factor: 60.716

5.  Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Authors:  G Gross; T Waks; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors:  Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal:  Science       Date:  2002-09-19       Impact factor: 47.728

7.  Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

Authors:  Renier J Brentjens; Jean-Baptiste Latouche; Elmer Santos; Francesc Marti; Michael C Gong; Clay Lyddane; Philip D King; Steven Larson; Mark Weiss; Isabelle Rivière; Michel Sadelain
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

8.  In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.

Authors:  P Hwu; J C Yang; R Cowherd; J Treisman; G E Shafer; Z Eshhar; S A Rosenberg
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

9.  Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.

Authors:  C Imai; K Mihara; M Andreansky; I C Nicholson; C-H Pui; T L Geiger; D Campana
Journal:  Leukemia       Date:  2004-04       Impact factor: 11.528

10.  T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

Authors:  Laurence J N Cooper; Max S Topp; Lisa Marie Serrano; Sergio Gonzalez; Wen-Chung Chang; Araceli Naranjo; Christine Wright; Leslie Popplewell; Andrew Raubitschek; Stephen J Forman; Michael C Jensen
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113
View more
  4 in total

1.  Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.

Authors:  Rasha Abu-Eid; Raed N Samara; Laurent Ozbun; Maher Y Abdalla; Jay A Berzofsky; Kevin M Friedman; Mikayel Mkrtichyan; Samir N Khleif
Journal:  Cancer Immunol Res       Date:  2014-07-30       Impact factor: 11.151

2.  Development of a novel universal immune receptor for antigen targeting: To Infinity and beyond.

Authors:  Katarzyna Urbanska; Daniel J Powell
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

3.  Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas.

Authors:  Catherine Flores; Christina Pham; David Snyder; Shicheng Yang; Luis Sanchez-Perez; Elias Sayour; Xiuyu Cui; Hanna Kemeny; Henry Friedman; Darell D Bigner; John Sampson; Duane A Mitchell
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

4.  'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.

Authors:  Debottam Sinha; Sriganesh Srihari; Kirrliee Beckett; Laetitia Le Texier; Matthew Solomon; Archana Panikkar; George R Ambalathingal; Lea Lekieffre; Pauline Crooks; Sweera Rehan; Michelle A Neller; Corey Smith; Rajiv Khanna
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.